focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Ghana kicks off coronavirus vaccination campaign with COVAX shots

Tue, 02nd Mar 2021 15:21

* President says Ghana to inoculate 20 million people by
year-end

* COVAX vaccines scheme accelerates deliveries

* Nigeria, Angola, Congo receive COVAX vaccines on Tuesday
(Updates with vaccine delivery to Congo and Gambia)

By Christian Akorlie

ACCRA, March 2 (Reuters) - Ghana launched its coronavirus
vaccination drive on Tuesday with doses from the global COVAX
vaccine-sharing programme, which delivered shipments to other
African countries as its vaccine rollout to developing nations
accelerates.

The start of vaccinations in Ghana, and in neighbouring
Ivory Coast on Monday, along with the expected delivery of
millions of vaccines from the COVAX programme this week, will
enable more poor countries to start inoculating mostly frontline
workers and the most vulnerable, months after wealthier
countries began.

COVAX is the programme backed by the World Health
Organization and GAVI vaccine alliance to provide vaccines for
poor and middle-income countries. It said on
Tuesday it aims to deliver 237 million doses of AstraZeneca's
shot to 142 countries by the end of May.

On Tuesday, COVAX delivered 3.92 million doses of the
vaccine to Nigeria, 1.7 million doses to Democratic Republic of
Congo, 624,000 to Angola and 36,000 to Gambia. Senegal expects
324,000 doses from the scheme to arrive on Wednesday.

"This is a historic and momentous occasion for The Gambia,"
Health Minister Ahmadou Lamin Samateh said in a statement.

In Ghana, people lined up outside the regional hospital in
the capital, Accra, for a first phase of vaccinations which is
prioritising frontline health workers and others at high risk.

"I feel so good about taking the vaccine. It will protect me
from contracting the virus from patients," said Bernice
Anaglatey, 42, who works in the COVID-19 intensive care unit at
Accra's Ridge Hospital as she queued for her shot.

The West African country aims to vaccinate 20 million
people, or over 66% of its population, by the end of 2021,
according to President Nana Akufo-Addo.

Drones from U.S.-based startup Zipline delivered some of the
vaccines to health facilities, making Ghana the first in the
world to use the technology on a national scale to deliver
COVID-19 shots, the company said.

Only a handful of other African countries have started
inoculations, with doses bought bilaterally or received as
donations.

Vaccine shipments through the COVAX scheme are expected to
accelerate this week with the delivery of 11 million AstraZeneca
and Pfizer-BioNTech doses.

Health authorities are also stepping up efforts to fight
conspiracy theories around the vaccines. President Akufo-Addo
and his wife were inoculated on Monday in an effort to boost
public confidence in the vaccines. nL5N2KY0W2]

"The stories I heard about the vaccine have put fear in me,"
said Isaac Armah, a 28-year-old trader in Accra. "I'll wait for
about two months to see the effects of the vaccine on the early
recipients, then I'll make up my mind."

Coronavirus infections in Ghana have surpassed 84,000 and
more than 600 people have died, according to health ministry
data.

(Reporting by Christian Akorlie
Additional reporting by Fiston Mahamba in Goma and Pap Saine in
Banjul, Writing by Nellie Peyton and Alessandra Prentice;
Editing by Bate Felix, Emelia Sithole-Matarise, Aurora Ellis and
Nick Macfie)

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.